Research & Development



  曹信匆匆的跑進屋子,見兩人鼾聲如雷,睡得深沉,廢了好大力氣才幫他們穿好褲頭。   對于這件事,雲瑯從來都回答的斬釘截鐵。财富彩票app下载安装   霍光之所以變成目前這種目中無人,膽子奇大的人,是有一定道理的。500万彩票软件下载   張安世用冰水洗了一把臉,眼楮紅的如同炭火一般,挑挑大拇指道︰“我看你嘴巴能硬到什麼地步。我根本就沒有打算從你們嘴里問出是誰干的。我只想讓你們極度的困倦,等你們睡的跟豬一樣,我就帶你們去富貴城……”   長安城是官城,沒有幾個人真正能住進去,而且,人們也不是很喜歡這座經常需要宵禁的城市。皇家娱乐彩票软件下载   熱氣球對霍光來說並不是一個很難的事情,很久以前他就萌生了要制造一個能把自己送上天的熱氣球。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo